Creafund invested in Purna to support its expansion and business-model shift
End 2003 Creafund provided growth capital to Purna in order to allow the company to achieve its growth plan. Creafund thereby obtained a minority stake.
![](https://www.creafund.be/Uploads/purna1-1.jpeg?crop=0,0,-0,-28)
![](https://www.creafund.be/Uploads/purna2.jpeg?crop=0,28,-0,-0)
![](https://www.creafund.be/Uploads/purna1-1-1.jpeg?maxwidth=600)
Purna is an independent Belgian company established in 1986, providing contract services for the development and manufacturing of powders, semi-solid and liquid pharmaceutical products that meet GXP standards as well as specific customer related requirements. Over the years, Purna has established a reputation for excellence and a global presence in the pharmaceutical industry, resulting in the status of preferred partner for most of the top-10 pharmaceutical multinationals. Purna’s agile and efficient operating model allows the company to successfully serve small start-ups with the same level of professional service that is afforded to its multinational pharmaceutical customers.